These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19390864)

  • 61. Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran.
    Ghotbi N; Tsukatani T
    East Mediterr Health J; 2005 May; 11(3):308-18. PubMed ID: 16602449
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Exploring the Effectiveness of Mandatory Premarital Screening and Genetic Counselling Programmes for β-Thalassaemia in the Middle East: A Scoping Review.
    Saffi M; Howard N
    Public Health Genomics; 2015; 18(4):193-203. PubMed ID: 26045079
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Geneticization: the Cyprus paradigm.
    Hoedemaekers R; ten Have H
    J Med Philos; 1998 Jun; 23(3):274-87. PubMed ID: 9736189
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Carrier testing in children and adolescents.
    Vears DF; Metcalfe SA
    Eur J Med Genet; 2015 Dec; 58(12):659-67. PubMed ID: 26563495
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.
    Barlow-Stewart K; Burnett L; Proos A; Howell V; Huq F; Lazarus R; Aizenberg H
    J Med Genet; 2003 Apr; 40(4):e45. PubMed ID: 12676918
    [No Abstract]   [Full Text] [Related]  

  • 66. Multimedia messages in genetics: design, development, and evaluation of a computer-based instructional resource for secondary school students in a Tay Sachs disease carrier screening program.
    Gason AA; Aitken M; Delatycki MB; Sheffield E; Metcalfe SA
    Genet Med; 2004; 6(4):226-31. PubMed ID: 15266211
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature.
    Van Steijvoort E; Chokoshvili D; W Cannon J; Peeters H; Peeraer K; Matthijs G; Borry P
    Hum Reprod Update; 2020 Apr; 26(3):335-355. PubMed ID: 32099997
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.
    Grinzaid KA; Page PZ; Denton JJ; Ginsberg J
    J Genet Couns; 2015 Jun; 24(3):381-7. PubMed ID: 25502003
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ACOG committee opinion. Number 318, October 2005. Screening for Tay-Sachs disease.
    ACOG Committee on Genetics
    Obstet Gynecol; 2005 Oct; 106(4):893-4. PubMed ID: 16199656
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
    Natowicz MR; Prence EM
    Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal.
    Zeesman S; Clow CL; Cartier L; Scriver CR
    Am J Med Genet; 1984 Aug; 18(4):769-78. PubMed ID: 6486173
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
    DeMarchi JM; Caskey CT; Richards CS
    Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The control of genetic disease by carrier screening and antenatal diagnosis: social, ethical, and medicolegal issues.
    Kaback MM
    Birth Defects Orig Artic Ser; 1982; 18(7):243-54. PubMed ID: 7159734
    [No Abstract]   [Full Text] [Related]  

  • 75. Genetic Carrier Screening in the Twenty-first Century.
    Yao R; Goetzinger KR
    Clin Lab Med; 2016 Jun; 36(2):277-88. PubMed ID: 27235912
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Estimating yields of prenatal carrier screening and implications for design of expanded carrier screening panels.
    Guo MH; Gregg AR
    Genet Med; 2019 Sep; 21(9):1940-1947. PubMed ID: 30846881
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Screening for Tay-Sachs disease: a note of caution.
    Rosner F
    J Clin Ethics; 1991; 2(4):251-2. PubMed ID: 1804394
    [No Abstract]   [Full Text] [Related]  

  • 78. Unique considerations for genetic counseling in community-based carrier screening programs.
    Rimoin DL; Greenwald S; Nathan TJ; Kaback MM
    Prog Clin Biol Res; 1977; 18():297-304. PubMed ID: 601081
    [No Abstract]   [Full Text] [Related]  

  • 79. Community-based genetic education: sources of information in a Tay Sachs disease screening program.
    Clark M; Palmer R; Kontras S
    Ohio State Med J; 1982 Mar; 78(3):218-20. PubMed ID: 7078924
    [No Abstract]   [Full Text] [Related]  

  • 80. Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.
    Schneider A; Nakagawa S; Keep R; Dorsainville D; Charrow J; Aleck K; Hoffman J; Minkoff S; Finegold D; Sun W; Spencer A; Lebow J; Zhan J; Apfelroth S; Schreiber-Agus N; Gross S
    Am J Med Genet A; 2009 Nov; 149A(11):2444-7. PubMed ID: 19876898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.